Financial reports
Current reports
8-K
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
1 Mar 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Results of Operations and Financial Condition
14 Feb 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Other Events
5 Jan 24
8-K
Departure of Directors or Certain Officers
5 Jan 24
8-K
Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates
3 Nov 23
8-K
Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates
7 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
16 Jun 23
8-K
Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting
17 May 23
Registration and prospectus
S-8
Registration of securities for employees
1 Mar 24
424B5
Prospectus supplement for primary offering
16 Feb 24
FWP
Free writing prospectus
14 Feb 24
424B5
Prospectus supplement for primary offering
14 Feb 24
S-3
Shelf registration
3 Nov 23
S-8
Registration of securities for employees
9 Mar 23
424B4
Prospectus supplement with pricing info
21 Oct 22
FWP
Free writing prospectus
19 Oct 22
S-1MEF
Registration of additional securities for an S-1
19 Oct 22
S-8
Registration of securities for employees
19 Oct 22
Other
EFFECT
Notice of effectiveness
14 Nov 23
CORRESP
Correspondence with SEC
9 Nov 23
UPLOAD
Letter from SEC
7 Nov 23
EFFECT
Notice of effectiveness
20 Oct 22
CERT
Certification of approval for exchange listing
19 Oct 22
SEC STAFF
SEC staff action: Order
19 Oct 22
CORRESP
Correspondence with SEC
17 Oct 22
CORRESP
Correspondence with SEC
17 Oct 22
CORRESP
Correspondence with SEC
17 Oct 22
UPLOAD
Letter from SEC
14 Oct 22
Ownership
4
Jeffrey D Marrazzo
4 Mar 24
3
Initial statement of insider ownership
29 Feb 24
SC 13G/A
GV 2019, L.P.
29 Feb 24
4
Keith Michael Gottesdiener
27 Feb 24
4
Richard Brudnick
23 Feb 24
4
Jeremy Duffield
23 Feb 24
4
ANN L. LEE
23 Feb 24
4
Meredith Goldwasser
23 Feb 24
4
Carman Alenson
23 Feb 24
SC 13D
ARCH Venture Fund XII, L.P.
22 Feb 24